Nonacus
Chris Sale is the Chief Executive Officer at Nonacus Ltd since May 2015. Prior to this role, Chris worked as a Consultant Genomics Business Manager at Agilent Technologies from May 2014 to April 2018. With a background in Biochemistry and Molecular Biology, Chris has held various sales and management positions in notable companies such as Illumina and Stratagene. Chris has extensive experience in managing commercial business and developing key accounts within the genomics industry.
Nonacus
Nonacus is focused on delivering innovative technologies to the genomic healthcare sector through the use of cell free circulating DNA as a non-invasive diagnostic tool. Nonacus was created by a team of highly motivated scientists and sector professionals with experience in translating research into routine diagnostic tools that benefit patients. Nonacus provides end to end validated solutions for the use of cell free DNA in genetic testing. Established in 2015 and located at the Birmingham BioHub UK we have been actively perfecting and refining our processes for use in healthcare diagnostics.